Projects per year
Fingerprint Dive into the research topics where Jason Taylor is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 3 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
- 1 Finished
Research Output
Switching patients in the age of long-acting recombinant products?
Escobar, M., Santagostino, E., Mancuso, M. E., Coppens, M., Balasa, V., Taylor, J. A., Iorio, A. & Negrier, C., Jan 14 2019, In : Expert Review of Hematology. 12, sup1, p. 1-13 13 p.Research output: Contribution to journal › Article
1
Scopus
citations
Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia
the Marzeptacog alfa (activated) Study Group Investigators, Oct 1 2018, In : Journal of Thrombosis and Haemostasis. 16, 10, p. 1984-1993 10 p.Research output: Contribution to journal › Article
4
Scopus
citations
Management of severe factor XI deficiency in cardiac surgery: A case report and review of the literature
Gay, N. D., Azar, S., Salomon, O. & Taylor, J., 2017, (Accepted/In press) In : Haemophilia.Research output: Contribution to journal › Article
3
Scopus
citations
Syndromes of Thrombotic Microangiopathy
Shatzel, J. J. & Taylor, J., Mar 1 2017, In : Medical Clinics of North America. 101, 2, p. 395-415 21 p.Research output: Contribution to journal › Review article
24
Scopus
citations
Unexpected pharmacokinetics of recombinant porcine factor VIII in a patient with acquired factor VIII deficiency and spontaneous epidural haematoma
Shatzel, J. J., Azar, S., Scherber, R., Gay, N., Deloughery, T., VanSandt, A., Kruse-Jarres, R., Recht, M. & Taylor, J., 2017, (Accepted/In press) In : Haemophilia.Research output: Contribution to journal › Article